Prosecution Insights
Prosecution Insights
5 pending office actions • 3 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| §112 only | 2 (40%) |
| Double-patenting only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOSHER, ERIC PARKER | 1 | — | — |
| DICKINSON, PAUL W | 1 | 62.8% | +9.9% |
| BAEK, JONGHWAN NMN | 1 | 75.0% | +0.0% |
| VAJDA, KRISTIN ANN | 1 | 84.0% | +10.9% |
| CRAIGO, BAHAR ALAWI | 1 | 46.8% | +27.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17600692 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | VAJDA, KRISTIN ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16619433 | RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY | CRAIGO, BAHAR ALAWI | 5d |
| 17600692 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | VAJDA, KRISTIN ANN | — |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| 1622 | 1 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18703995 | METHODS OF TREATING CANCER | MOSHER, ERIC PARKER | — | §103§112DP | Non-Final OA | — | Pending | Apr 23, 2024 |
| 18541618 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOX | DICKINSON, PAUL W | — | DP | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18541584 | COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND FOLFIRINOX | BAEK, JONGHWAN NMN | 1618 | §103Other | Non-Final OA | — | Pending | Dec 15, 2023 |
| 17600692 | HSP90-BINDING CONJUGATES AND FORMULATIONS THEREOF | VAJDA, KRISTIN ANN | 1622 | §112 | Final Rejection | — | Pending | Oct 01, 2021 |
| 16619433 | RADIOIMMUNOCONJUGATES AND DNA DAMAGE AND REPAIR INHIBITOR COMBINATION THERAPY | CRAIGO, BAHAR ALAWI | 1699 | §112Other | Non-Final OA | 5d | Pending | Dec 04, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial